Jason Zemansky
Stock Analyst at B of A Securities
(3.73)
# 844
Out of 4,412 analysts
17
Total ratings
53.33%
Success rate
9.37%
Average return
Main Sectors:
Top Industries:
10 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ALVR AlloVir | Downgrades: Underperform | $17 → $1 | $0.80 | +25.45% | 2 | Dec 26, 2023 | |
SNDX Syndax Pharmaceuticals | Initiates: Buy | $29 | $21.06 | +37.70% | 1 | Oct 25, 2023 | |
INSM Insmed | Maintains: Buy | $35 → $37 | $24.80 | +49.19% | 2 | Sep 6, 2023 | |
RCUS Arcus Biosciences | Maintains: Neutral | $21 → $23 | $15.55 | +47.91% | 2 | Sep 5, 2023 | |
KURA Kura Oncology | Initiates: Buy | $31 | $19.65 | +57.76% | 1 | Aug 11, 2023 | |
RPHM Reneo Pharmaceuticals | Initiates: Buy | $23 | $1.67 | +1,277.25% | 1 | Jul 3, 2023 | |
ESPR Esperion Therapeutics | Upgrades: Buy | $1.25 → $4 | $1.90 | +110.53% | 3 | Jun 15, 2023 | |
HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $6.75 | +48.15% | 3 | May 12, 2023 | |
CYTK Cytokinetics | Initiates: Neutral | $49 | $65.34 | -25.01% | 1 | Feb 17, 2023 | |
ALLK Allakos | Maintains: Buy | n/a | $1.02 | - | 1 | Dec 13, 2021 |
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17 → $1
Current: $0.80
Upside: +25.45%
Syndax Pharmaceuticals
Oct 25, 2023
Initiates: Buy
Price Target: $29
Current: $21.06
Upside: +37.70%
Insmed
Sep 6, 2023
Maintains: Buy
Price Target: $35 → $37
Current: $24.80
Upside: +49.19%
Arcus Biosciences
Sep 5, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $15.55
Upside: +47.91%
Kura Oncology
Aug 11, 2023
Initiates: Buy
Price Target: $31
Current: $19.65
Upside: +57.76%
Reneo Pharmaceuticals
Jul 3, 2023
Initiates: Buy
Price Target: $23
Current: $1.67
Upside: +1,277.25%
Esperion Therapeutics
Jun 15, 2023
Upgrades: Buy
Price Target: $1.25 → $4
Current: $1.90
Upside: +110.53%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $6.75
Upside: +48.15%
Cytokinetics
Feb 17, 2023
Initiates: Neutral
Price Target: $49
Current: $65.34
Upside: -25.01%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.02
Upside: -